In a focused review of AAE associated with B-cell lymphoproliferative disorders, Castelli et al. described neutralizing anti-C1-INH autoantibodies and immune-complex-driven consumption as the principal mechanisms lowering antigenic and functional C1-INH, with angioedema activity often tracking the hematologic process [9]. This evidence concerns the gene SERPING1 and acquired angioedema.